Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.80EUR
343.00 MEUR
5.25 BEUR
116.75 M
About UCB
Sector
CEO
Jean-Christophe Tellier
Headquarters
Brussels
Website
Employees (FY)
9.08 K
Founded
1925
ISIN
BE0003739530
FIGI
BBG000G3FZD7
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on TURQUOISE exchange UCB SA stocks are traded under the ticker UCBB.
We've gathered analysts' opinions on UCB SA future price: according to them, UCBB price has a max estimate of 170.00 EUR and a min estimate of 105.00 EUR. Watch UCBB chart and read a more detailed UCB SA stock forecast: see what analysts think of UCB SA and suggest that you do with its stocks.
UCBB reached its all-time high on Jun 24, 2024 with the price of 139.85 EUR, and its all-time low was 29.20 EUR and was reached on Mar 2, 2012. View more price dynamics on UCBB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track UCB SA financials in yearly and quarterly reports right on TradingView.
UCB SA is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
UCBB earnings for the last half-year are 1.56 EUR per share, whereas the estimation was 1.34 EUR, resulting in a 16.42% surprise. The estimated earnings for the next half-year are 1.67 EUR per share. See more details about UCB SA earnings.
UCB SA revenue for the last half-year amounts to 2.66 B EUR, despite the estimated figure of 2.54 B EUR. In the next half-year revenue is expected to reach 2.60 B EUR.
UCBB net income for the last half-year is 32.00 M EUR, while the previous report showed 311.00 M EUR of net income which accounts for −89.71% change. Track more UCB SA financial stats to get the full picture.
Yes, UCBB dividends are paid annually. The last dividend per share was 0.95 EUR. As of today, Dividend Yield (TTM)% is 0.69%. Tracking UCB SA dividends might help you take more informed decisions.
UCB SA dividend yield was 1.21% in 2023, and payout ratio reached 52.65%. The year before the numbers were 1.27% and 42.23% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 1, 2024, the company has 9.08 K employees. See our rating of the largest employees — is UCB SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UCB SA EBITDA is 1.35 B EUR, and current EBITDA margin is 18.47%. See more stats in UCB SA financial statements.
Like other stocks, UCBB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UCB SA stock right from TradingView charts — choose your broker and connect to your account.